• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,891.50 14.41
(0.03%)
Dow Jones
7,684.38 -93.79
(-1.21%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.51 -0.31
(-0.33%)
EUR-INR
106.10 -0.35
(-0.33%)
GBP-INR
126.51 -0.13
(-0.10%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2353295
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
51.08
9199.3
EPS(TTM)
Face Value()
Div & Yield %
19.54
10
0.5
 

Tejnaksh Healthcare consolidated net profit declines 29.41% in the March 2026 quarter
Jun 01,2026
Net profit of Tejnaksh Healthcare declined 29.41% to Rs 0.36 crore in the quarter ended March 2026 as against Rs 0.51 crore during the previous quarter ended March 2025. Sales declined 20.56% to Rs 2.55 crore in the quarter ended March 2026 as against Rs 3.21 crore during the previous quarter ended March 2025.

For the full year,net profit declined 47.21% to Rs 1.23 crore in the year ended March 2026 as against Rs 2.33 crore during the previous year ended March 2025. Sales declined 16.36% to Rs 10.79 crore in the year ended March 2026 as against Rs 12.90 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.553.21 -21 10.7912.90 -16
OPM %27.8422.12 -25.7631.63 -
PBDT0.880.77 14 3.074.10 -25
PBT0.520.59 -12 1.653.19 -48
NP0.360.51 -29 1.232.33 -47